GitLab (NASDAQ: GTLB) is trading largely unchanged following a volatile post-Earningsreaction that highlighted the market's conflicting views on the software company's future.
Ulta Beauty (NASDAQ: ULTA) delivered a fiscal first-quarter report that, on the surface, appeared to check all the right boxes. The beauty retailer exceededEarningsexpectations, generated solid revenue growth, and raised its full-year profit outlook.
Five Below (NASDAQ: FIVE) reported one of the strongest quarters in the discount retailer's recent history, yet the stock is tumbling nearly 10% as investors focus on risks beyond the headline numbers.
The AI revolution is not just a software story. It is an electricity story.Trainingand running large language models, managing hyperscale data centers, and powering AI inference workloads requires enormous and uninterrupted powerSupplyat a scale that is forcing technology companies to fundamentally rethink their energy …
The macro environment entering June 2026 is precisely the kind of backdrop that forces investors to think seriously about defensive positioning. Oil prices are pushing toward $100 per barrel driven by escalating Iran–U.S. military tensions — a geopolitical risk catalyst that historically triggers risk-off …
Applied Materials just raised its full-year semiconductor equipment growth outlook to over 30%. Micron reported Q2Revenueof $23.86 billion — up 196% year-over-year. ASML’sBacklogstands at $45 billion. Arm’sData Centerroyalties doubled. The question is no longer whether the supercycle is real. It is how long it …
Artificial intelligence has evolved from a promising technology trend into one of the largestCapital Expenditurecycles in modern history. Microsoft, Amazon, Meta, and Alphabet are collectively committing hundreds of billions of dollars to AI-ready data centers, advanced semiconductors, networking infrastructure, and the power and cooling …
The defense spending environment in 2026 is unlike anything seen in the post-Cold War era. NATO members are moving toward — and in several cases beyond — the alliance’s 2% GDP defense spending target, while the United States continues to prioritize technological superiority across …
The Divergence Between Economic Noise and Structural Change
Verastem Oncology (NASDAQ: VSTM) moved higher after the US Food and Drug Administration granted Fast Track Designation to VS-7375, the company’s oral investigational selective KRAS G12D inhibitor, for a defined group of patients with advanced or metastatic non-small cell lung cancer.